Panel discussion: Next gen pharma labs: Techniques, technology and adapting to rapid changes to…
The experts also pointed out how COVID-19 has highlighted gaps in our current processes and asked the industry to learn from the…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
Keynote address: Making sense of good quality by design in the 2020s
To become future-ready, it is important to improve traceability and integrity. He said Industry 4.0 stressed that by 2030 there is…
An integrated laboratory informatics system for greater efficiency and data integrity
Lab operation is complex, which means that any analytical lab deals with a variety of instruments. When there are a huge number of…
Panel Discussion: Trends in lab design
They enlightened the audience about the innovation in lab designs so that there is flexibility, compliance, etc
Panel discussion: Lab informatics: Revolutionising pharma R&D
As newer solutions enter the market, international bodies are trying to bring in standardisation in this field
Recent advances in solid state drug product characterisation
Since the surface of a tablet is in contact with the external environment, the formulator has to be very careful
Pharma infra: Gearing for new realities
As India Pharma Inc makes the shift from volume-based care to value-based care, it has to invest in robust R&D and…
Packaging trends and innovations to prevent counterfeiting
Since the world witnessed numerous cases of counterfeit COVID vaccines, it is necessary for the pharma industry across the globe…
Raising GMP standards for vaccines
India has huge vaccine manufacturiing capabilities but ensuring strict adherence to Good Manufacturing Practices (GMP) will be…
Achieving Aatmanirbharta in APIs: Are we on the right track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a goal for the pharma sector.…
Equipping Progress
The lab equipment market is expected to boom as investments in life sciences R&D increase to deal with existing and emerging…
Reaffirming commitment to sustainability
As the pharma sector battles the COVID-19 pandemic and goes through a reset to defend the world against such crises in future, it…
Future-ready supply chains
The COVID-19 pandemic has several lessons for India Pharma Inc as it embraces new strategies and technologies to rebuild and…
Cyber resilience: A high priority
The COVID-19 pandemic has accelerated digitalisation and automation in the pharma sector. But, as the risk landscape of the pharma…
Blueprint for progress
Experts and veterans examine and explore strategies for India Pharma Inc to implement the lessons learnt from the COVID-19…
What COVID-19 taught us
In this year-ender edition, experts reflect on the biggest lessons for India Pharma Inc from the current pandemic
Drugs & Cosmetics Act, 1940: Recommendations for a revamp
The existing Drugs and Cosmetics Act of 1940 was formed during the pre-independence era. Since then, amendments have been made to…
COVID-19 vaccine delivery: Prepping for challenge extraordinaire
India will have a very strategic role to play in ensuring universal access to COVID-19 vaccines. All stakeholders must step up…
WHO reviewing report urging new guidance over airborne spread of coronavirus
How frequently the coronavirus can spread by the airborne or aerosol route - as opposed to by larger droplets in coughs and…
WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce death
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day